Grown Rogue International (GRUSF) Retained Earnings (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Retained Earnings came in at -$121906.0 in Q1 2026, up 99.62% year-on-year from -$61069.9 in Q1 2025, and little changed quarter-over-quarter from -$121906.0 in Q4 2025.
Grown Rogue International (GRUSF) Retained Earnings (2009 - 2026) Analysis & Trends
Grown Rogue International's Retained Earnings history runs 18 years deep, the most recent figure standing at -$121906.0 for Q1 2026.
- On a quarterly basis, Retained Earnings rose 99.62% year-over-year to -$121906.0 in Q1 2026; TTM through Mar 2026 was -$121906.0, a 99.62% increase from a year earlier, with the FY2025 full-year figure at -$121906.0, up 3.2% from the prior year.
- Retained Earnings held at -$121906.0 in Q1 2026 per GRUSF's latest filing, from -$121906.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $8.1 million in Q4 2023 and bottomed at -$27754.9 billion in Q3 2025.
- The 5-year median for Retained Earnings is -$20.4 million (2022), against an average of -$1982.5 billion.
- Across the five-year window, Retained Earnings soared 137.84% in 2023 and sank 108533437.45% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$21.4 million in 2022, then climbed by 30.0% to -$15.0 million in 2023, then jumped by 99.16% to -$125930.0 in 2024, then grew by 3.2% to -$121906.0 in 2025, then changed by 0.0% to -$121906.0 in 2026.
- Per Business Quant, the three latest GRUSF Retained Earnings figures stand at -$121906.0 (Q1 2026), -$121906.0 (Q4 2025), and -$27754.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | -121,906.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -121,906.00 |
| Dec 31, 2025 | -121,906.00 |
| Sep 30, 2025 | -27,754.87 Bn |
| Jun 30, 2025 | -30.52 Mn |
| Mar 31, 2025 | -31.84 Mn |
| Dec 31, 2024 | -125,930.00 |
| Sep 30, 2024 | -25.57 Mn |
| Jun 30, 2024 | -25.43 Mn |
| Mar 31, 2024 | -24.55 Mn |
| Dec 31, 2023 | -14.95 Mn |
| Oct 31, 2023 | 8.08 Mn |
| Apr 30, 2023 | -19.12 Mn |
| Jan 31, 2023 | -19.53 Mn |
| Oct 31, 2022 | -21.36 Mn |
| Oct 31, 2021 | -21.80 Mn |
| Apr 30, 2021 | -21.74 Mn |
| Jan 31, 2021 | -20.39 Mn |
| Oct 31, 2020 | 4.07 Mn |
| Jul 31, 2020 | -19.31 Mn |
| Apr 30, 2020 | -18.52 Mn |